Researchers conducted a systematic review of randomized controlled trials and crossover studies involving the efficacy and safety of PPIs in children with GERD. They found that infants’ GERD symptoms did not consistently improve from PPIs. Results for children and adolescents showed that PPIs were equally effective as alginates, ranitidine or a different PPI dosage.
The review also found six studies in which treatment-related adverse events were similar for PPIs, placebo and a different PPI dosage.
The authors suggest a need for more placebo-controlled trials in older children and studies of the safety of PPIs.
Read the Pediatrics abstract on proton-pump inhibitors for children with gastroesophageal reflux disease.
Read more coverage on GI issues:
– Obesity Surgery Could Improve Memory
– Educational Booklet Promotes Improved Preparation for Colonoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.